VIM is considered a biomarker of mesenchymal-derived cells and cancer cells undergoing epithelial-mesenchymal transition (EMT) during invasion and metastasis, and promoter methylation of VIM has been documented in CRC [1]. This evidence concerns the gene VIM and cancer.